首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2192篇
  免费   64篇
  国内免费   62篇
耳鼻咽喉   3篇
儿科学   55篇
妇产科学   58篇
基础医学   260篇
口腔科学   16篇
临床医学   150篇
内科学   590篇
皮肤病学   14篇
神经病学   59篇
特种医学   152篇
外科学   360篇
综合类   204篇
预防医学   50篇
眼科学   5篇
药学   101篇
  1篇
中国医学   46篇
肿瘤学   194篇
  2023年   43篇
  2022年   79篇
  2021年   109篇
  2020年   79篇
  2019年   56篇
  2018年   84篇
  2017年   58篇
  2016年   62篇
  2015年   83篇
  2014年   129篇
  2013年   153篇
  2012年   90篇
  2011年   113篇
  2010年   90篇
  2009年   114篇
  2008年   128篇
  2007年   110篇
  2006年   100篇
  2005年   73篇
  2004年   52篇
  2003年   41篇
  2002年   38篇
  2001年   32篇
  2000年   38篇
  1999年   37篇
  1998年   23篇
  1997年   23篇
  1996年   32篇
  1995年   14篇
  1994年   11篇
  1993年   29篇
  1992年   22篇
  1991年   10篇
  1990年   16篇
  1989年   8篇
  1988年   16篇
  1987年   11篇
  1986年   6篇
  1985年   20篇
  1984年   16篇
  1983年   11篇
  1982年   9篇
  1981年   10篇
  1980年   5篇
  1979年   9篇
  1978年   2篇
  1977年   10篇
  1974年   2篇
  1973年   4篇
  1971年   4篇
排序方式: 共有2318条查询结果,搜索用时 31 毫秒
1.
2.
Interstitial cystitis/bladder pain syndrome (IC/BPS) and vulvodynia are chronic pain syndromes that appear to be intertwined from the perspectives of embryology, pathology and epidemiology. These associations may account for similar responses to various therapies.  相似文献   
3.
4.
靶向持续性组织间化疗治疗舌鳞癌的初步观察   总被引:3,自引:2,他引:1  
目的观察靶向持续性组织间化疗治疗舌癌的疗效及安全性。方法将顺铂(缓释型)植入于10例舌癌患者癌区周围及中央,观察局部变化、全身反应与术后标本的病理结果。结果所有患者原发灶都有不同程度的缩小,部分缓解8例,无效2例(缩小约30%左右),有效率为80%。所有患者术后标本肉眼见肿块边缘药物所在区形成比较明显的纤维组织样反应;镜下见癌中央组织凝固性坏死,植入药物周围组织变性、坏死,转移淋巴结内可见部分坏死灶、组织变性。结论顺铂(缓释型)治疗舌鳞癌,疗效较好,操作简单,安全性高,毒副作用少,对转移淋巴结有一定的治疗作用。  相似文献   
5.
OBJECTIVE: This study was designed to determine the relationship between interstitial cystitis (IC), endometriosis (endo), and chronic pelvic pain (CPP) in individuals in whom nongynecological and nonurological problems had been previously ruled out. METHODS: A prospective study of 162 consecutive women with a complaint of chronic pelvic pain seen in the clinic was performed between August 2002 and December 2005. These patients underwent a workup to exclude other causes of pelvic pain, had PUF (Pain Urgency and Frequency) questionnaires filled out, and underwent a laparoscopy and a cystoscopy with hydrodistention. Pain levels were determined, and treatment was reviewed and enumerated. Results were obtained and quantified. RESULTS: In this study, 123 (76%) patients were diagnosed with active endometriosis, 133 (82%) were diagnosed with interstitial cystitis, and 107 (66%) had both disease entities simultaneously. Thirteen (8%) patients were diagnosed with pathologies unrelated to endometriosis and interstitial cystitis. Pain levels were seen to decrease at 6 months in all groups of patients with the exception of those patients with endometriosis only. CONCLUSION: CPP is a difficult, taxing, and frustrating concern for many women in the United States. These individuals have traditionally been difficult to treat. A large number of women with CPP in our patient population have been shown to have endometriosis, interstitial cystitis, or both. Therefore, a workup for premenopausal individuals with CPP involves obtaining a history that keys into possible nongynecologic causes of pain, a complete accounting of urinary problems, and a thorough history of gynecological problems. A physical examination with a comprehensive history should be performed, and the investigation may include the possibility of a simultaneous laparoscopy and cystoscopy if warranted. These procedures can serve as both a means for diagnosis and treatment of these problems when encountered.  相似文献   
6.
To examine the incidence of interstitial and vascular rejection in pancreas allografts and its impact on graft survival, we studied 36 percutaneous pancreas biopsies and 10 pancreas transplantectomy specimens from 32 patients who had undergone simultaneous pancreas-kidney transplantation. Interstitial rejection (IR) was predominantly found in the biopsies, while vascular rejection (VR) was most prominent in the transplantectomies. Pancreas graft survival was significantly decreased for pancreas grafts that had suffered from vascular rejection when compared to those with only interstitial rejection. Potential rejection markers, i. e., serum amylase, glucose, creatinine, and urinary amylase, did not correlate with histological signs of rejection, although increased levels of serum amylase were, in all but one case, associated with rejection.We conclude that a percutaneous pancreas biopsy remains the most reliable method to determine pancreas rejection, and that by distinguishing between IR andVR, a pancreas biopsy may provide important diagnostic as well as prognostic information. Received: 6 March 1997 Received after revision: 5 June 1997 Accepted: 30 June 1997  相似文献   
7.
慢传输型便秘模型的建立及其机制探讨   总被引:13,自引:0,他引:13  
目的 :建立实验型慢传输型便秘模型。 方法 :实验组小鼠皮下注射吗啡建立慢传输型便秘模型 ,记录小鼠粪便重量 ,利用炭沫推进试验比较实验组与对照组小鼠结肠传输功能 ;利用免疫组化技术比较两组小鼠结肠组织中Cajal细胞数量。 结果 :实验组小鼠粪便重量减轻 (P <0 .0 1) ,结肠推进率较对照组明显延长 (P <0 .0 1) ,Ca jal细胞数量较对照组明显减少 (P <0 .0 1)。 结论 :吗啡皮下注射诱导小鼠结肠慢传输型便秘模型符合疾病的基本特点 ,其发病机制可能与内源性阿片肽增多和 (或 )肠道Cajal细胞异常改变有关  相似文献   
8.
The authors present their first experience with laser interstitial thermotherapy, (ITT). Four patients with deep-seated non-infiltrative benign tumours (three astrocytomas, one oligodendrocytoma) underwent ITT. Previously, a stereotactic procedure had been performed to determine the exact location of the tumour, its spatial configuration and its histological diagnosis. The MRI controls confirmed the efficacy of hyperthermia on the tumour tissues. The authors discuss the possible ITT mechanisms. The indications of such laser ITT in neurosurgery should be enlarged to malignant tumours (gliomas, metastases) and to certain hypophyseal adenomas.  相似文献   
9.
肝素膀胱灌注治疗间质性膀胱炎   总被引:10,自引:1,他引:9  
目的 观察肝素膀胱灌注治疗间质性膀胱炎的疗效。 方法  17例间质性膀胱炎患者 ,均为女性。平均年龄 35岁。平均病程 2 7个月。临床表现主要为尿频及膀胱区疼痛。膀胱镜检见黏膜下点状出血 15例 ,Hunner溃疡 2例。按O’Leary Sant间质性膀胱炎症状评分 (ICSI) 8~ 18分 ,平均 (13.4± 3.5 )分 ;问题评分 (ICPI) 3~ 12分 ,平均 (8.2± 3.4 )分。所有患者均使用肝素钠 10 5U膀胱灌注 ,每周 3次 ,疗程 4周。观察治疗后患者症状改善情况。 结果  17例患者随访 3~ 12个月 ,平均 6个月 ,症状缓解 14例 ,其中症状显著缓解或消失 9例 ,评分下降 7分 ;症状部分缓解 5例 ,评分下降 >3分 ;无效 3例。 2例于治疗 7个月及 9个月症状复发。有效率 82 %。治疗后 1、2个月ICSI分别降至 (6 .1± 3.4 )、(6 .3± 3.5 )分 ,ICPI分别降至 (3.5± 2 .9)、(3.6± 2 .7)分 ,治疗前后比较差异有显著性意义 (P <0 .0 1)。治疗期间发生一过性尿道灼痛者 2例 ,轻微肉眼血尿 1例。 结论 肝素膀胱灌注治疗可有效缓解间质性膀胱炎患者症状 ,提高生活质量。  相似文献   
10.

Objective

Interstitial lung disease (ILD) is the most severe complication of idiopathic inflammatory myositis (IIM), resulting in significant increase in morbidity and mortality and for which the best treatment remains controversial. We conducted a meta-analysis to evaluate the efficacy of therapies used for the management of IIM-related ILD.

Methods

Studies were selected from MEDLINE up to July 2017. Two investigators independently extracted data on study design, patient characteristics, clinical features, treatment, follow-up and outcomes. Global survival rates and objectively confirmed lung function improvements were extracted as the main outcome for rapidly progressive IIM-related ILD (RP-ILD) and chronic forms of ILD (C-ILD), respectively, and pooled using the weighted mean proportion with fixed or random-effects models in case of significant heterogeneity (I2?>?50%).

Results

Twenty-seven studies encompassing 553 patients (male: 30.5%, age: 53.5?±?5.5?years) were included in the meta-analysis. Globally, retrieved studies were of limited methodological quality (no controlled studies and only 2 prospective studies). Dermatomyositis (40%) and anti-tRNA synthetase syndrome (45%) were the most represented IIM subtypes. In C-ILD, functional improvement rates were 89.2% (95%CI 82.5–93.6; 7 studies, n?=?124) for corticosteroids alone, 80.7% (95%CI 49.6–94; 6 studies, n?=?38) for cyclosporine A, 64.1% (95%CI 46.3–78.7; 4 studies, n?=?32) for azathioprine, 86.2% (95%CI 61.5–96; 2 studies, n?=?23) for tacrolimus, 56.4% (95%CI 44–68.0; 8 studies, n?=?71) for cyclophosphamide, and 76.6% (95%CI 50.4–96.0; 2 studies, n?=?20) for rituximab. In RP-ILD, survival rates at 3?months were 51.7% (95%CI 24.2–78.1; 2 studies, n?=?11) for corticosteroids alone, 69.2% (95%CI 55.0–80.5; 8 studies, n?=?146) for cyclosporine A and 72.4% (95%CI 6.4–99.0, 2 studies, n?=?16) for cyclophosphamide.

Conclusion

Despite aggressive immunosuppressive therapies, the short-term mortality of RP-ILD remains high. While immunosuppressive therapies are associated with significant functional improvements in most patients with C-ILD, substantial uncertainty remains about the best treatment strategy in the absence of good quality evidence.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号